A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Quinidine barbiturate
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ceritinib.
Quinidine barbiturate
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Ceritinib.
Quinidine barbiturate
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Ceritinib.
Quinidine barbiturate
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Ceritinib.
Quinidine barbiturate
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Ceritinib.
Quinidine barbiturate
Encorafenib
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Encorafenib.
Quinidine barbiturate
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Dexchlorpheniramine.
Quinidine barbiturate
Lorcainide
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Lorcainide.
Quinidine barbiturate
Bunaftine
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Bunaftine.
Quinidine barbiturate
Nizofenone
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Nizofenone.
Quinidine barbiturate
Sultopride
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Sultopride.
Quinidine barbiturate
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Sitafloxacin.
Quinidine barbiturate
Oxatomide
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Oxatomide.
Quinidine barbiturate
Abexinostat
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Abexinostat.
Quinidine barbiturate
Mizolastine
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Mizolastine.
Quinidine barbiturate
Ricolinostat
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Ricolinostat.
Quinidine barbiturate
Simendan
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Simendan.
Quinidine barbiturate
CUDC-101
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with CUDC-101.
Quinidine barbiturate
Entinostat
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Entinostat.
Quinidine barbiturate
Mocetinostat
The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Mocetinostat.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3